Paolo Ghia
Impact in
- Genetics top 0.02%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 344
- Chronic Lymphocytic Leukemia Research 344
-
- Lymphoma Diagnosis and Treatment 177
- Co-authors
- Federico Caligaris‐Cappio (81 shared papers)Cristina Scielzo (46 shared papers)Lydia Scarfò (79 shared papers)Κώστας Σταματόπουλος (84 shared papers)Peter Hillmen (43 shared papers)Jan A. Burger (19 shared papers)Tadeusz Robak (30 shared papers)Massimo Geuna (10 shared papers)
- Journals
- Blood (117 papers)Journal of Clinical Oncology (35 papers)HemaSphere (27 papers)Leukemia (21 papers)Haematologica (19 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Paolo Ghia
381 papers receiving 12.8k citations
Paolo Ghia's Hit Papers
Peers
Comparison fields: 5 of 126
- Genetics 8.6k
- Pathology and Forensic Medicine 5.4k
- Immunology 5.3k
- Hematology 2.0k
- Oncology 2.2k
Countries citing papers authored by Paolo Ghia
This map shows the geographic impact of Paolo Ghia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Ghia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Ghia more than expected).
Fields of papers citing papers by Paolo Ghia
This network shows the impact of papers produced by Paolo Ghia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Ghia. The network helps show where Paolo Ghia may publish in the future.
Co-authors
The 25 scholars most cited alongside Paolo Ghia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 408 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 424 | |
| 2 | Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2015 | 424 |
| 3 | Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2020 | 348 |
| 4 | Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study Hit paper breakdown → | 2019 | 320 |
| 5 | 2001 | 272 | |
| 6 | 2005 | 264 | |
| 7 | ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia Hit paper breakdown → | 2020 | 259 |
| 8 | 2009 | 234 | |
| 9 | 2007 | 224 | |
| 10 | 2002 | 200 | |
| 11 | 2003 | 178 | |
| 12 | 2008 | 173 | |
| 13 | 2003 | 166 | |
| 14 | Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia Hit paper breakdown → | 2022 | 163 |
| 15 | 2004 | 154 | |
| 16 | 1995 | 152 | |
| 17 | 2008 | 147 | |
| 18 | 1996 | 147 | |
| 19 | 2004 | 140 | |
| 20 | Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort Hit paper breakdown → | 2022 | 139 |
About Paolo Ghia
Paolo Ghia is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Hematology and Oncology, having authored 408 papers that have together received 12.9k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (344 papers), Lymphoma Diagnosis and Treatment (177 papers), Immunodeficiency and Autoimmune Disorders (90 papers), Chronic Myeloid Leukemia Treatments (48 papers), Monoclonal and Polyclonal Antibodies Research (38 papers), Advanced Breast Cancer Therapies (38 papers), Immune Cell Function and Interaction (36 papers) and CAR-T cell therapy research (26 papers). The work is most often cited by research in Genetics (8.6k citations), Pathology and Forensic Medicine (5.4k citations), Immunology (5.3k citations), Hematology (2.0k citations) and Oncology (2.2k citations). Paolo Ghia has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Federico Caligaris‐Cappio, Cristina Scielzo, Lydia Scarfò, Κώστας Σταματόπουλος, Peter Hillmen, Jan A. Burger, Tadeusz Robak, Massimo Geuna, Michael Hallek and Marta Muzio. Their work appears in journals such as Blood, Journal of Clinical Oncology, HemaSphere, Leukemia and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.